🔗 Share this article

An underground market for unlicensed slimming drugs is propelled by social media fitness personalities and sellers on communication apps, based on recent findings.

Experimental Drug Gaining Traction Online

Retatrutide, which is still in clinical trials, is being advertised by online personalities for its alleged fat-burning properties. Viewers are encouraged to message these profiles privately for supplier links, while also obtaining discount codes.

Thriving Trade on Social Networks

Separately, a flourishing trade exists on messaging services, where communities with thousands of participants share “before and after” images, injection guides and claims of next-day British shipping. Sellers market the substance there before directing customers to WhatsApp for transactions.

Understanding Retatrutide

This medication is an investigational injection developed by US drugmaker Eli Lilly. The treatment affects three intestinal hormones – GLP-1, glucose-dependent insulinotropic polypeptide and pancreatic hormone. Preliminary studies indicate it could help individuals lose up to 25% of their total weight. Referred to as the “triple G”, the drug is being hailed digitally as the next Ozempic.

Medical Experts Express Worries

However, physicians and pharmacists have cautions that the distribution of what is still an unapproved drug in the UK is a cause for concern and could lead to individuals injecting substances of uncertain source.

Some experts said the demand for retatrutide could be connected to the increasing price of licensed weight loss products such as Mounjaro.

Legal Position and Implementation

Marketing retatrutide on TikTok or Telegram is prohibited in the UK, as it is an unlicensed drug that cannot be marketed or supplied for human use under the British medical regulations.

Some influencers attempt to sidestep the rules by referring to the drug as a “research chemical” or describing it as “not for human consumption”. The substance is not a restricted drug, but promotion and supply can still breach medicines, marketing, and consumer laws, potentially leading to penalties, legal action or prison.

Service Response and Content Removal

Based on the social media company, the platform has taken down problematic content and banned associated hashtags and search suggestions. The company said it was committed to maintaining the platform secure and investing in enhancing enforcement strategies.

Digital Trading Activities

Investigations also discovered communities with up to 9,000 participants marketing the experimental drug using Telegram's integrated discovery tool, which functions like a public directory. Typing “retatrutide” immediately displays groups with numerous of members, populated with photos of weight loss, glowing reviews and detailed guides for mixing or administering at residence.

Within moments of entering one community, a seller shared contact information, where the majority of transactions occur. The seller sent an instruction manual and guaranteed shipping within two days. When asked whether the product was authentic, one vendor said: “You can’t be sure.” Another shared a photo of a supposed laboratory certificate. Not one inquired about weight, medical conditions or previous experience.

Product Information and Costs

Inside these communities, posts show dark colored parcels with postal service labels, stating to contain new batches. One communication stated: “It took eight of us to load them this morning.”

Buyers can choose between dry substance containers, prepared at residence with purified liquid, or ready-to-use pens typically priced at 160 pounds for 20mg. When asked how long a injector should be used, sellers give conflicting responses ranging from a several days to “depends on your body”.

Service Moderation and Security Actions

A spokesperson for the messaging service stated it regularly monitored dangerous material on its platform including material that promoted the “misuse of controlled medications”. The organization noted that it eliminated “millions of pieces of harmful content each day”.

Healthcare Expert Warnings

“Individuals are injecting materials they cannot confirm. Although the science behind this drug is sound, these digital products may not include what they claim,” stated a pharmacy expert, the director of pharmacy at a pharmacy service.

Dr Crystal Wyllie of an online medical service connected the increase in demand to current cost increases for authorized weight-loss medications such as Mounjaro. “With costs increasing, patients are using social media. But fake injections are highly dangerous. You can’t be certain what’s contained or whether the conditions they were produced in was clean,” she said.

Her team has already seen patients injured by personal administration from unverified sources. “We recognize the disappointment, but purchasing from messaging apps or communication platforms is gambling with your well-being,” stated the doctor. “These substances could be contaminated or improperly measured.”

Manufacturer Statement

A representative from the pharmaceutical company stated retatrutide was in third stage research studies and had not been evaluated or authorized by any regulatory agency globally. “Consequently at this time no one can market [it] for personal consumption,” they said, noting that any item “falsely representing itself as a Lilly experimental substance not yet approved … may expose patients to potentially serious health risks”.